EXPLAINER | Pharma exports: Quality issue in made-in-India drugs financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers.
While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies.
The Schedule M of the Drugs and Cosmetics Rules specifies the good manufacturing practices (GMPs), which aim to ensure quality of drugs made in the country.
After the World Health Organization (WHO) warned that it suspected four cough syrups could be linked to the deaths of 66 children in Gambia, the Delhi-based manufacturer, Maiden Pharmaceuticals, is in the news. The syrups, the WHO said, have been “potentially linked with acute kidney injuries and 66 deaths among children.” The global body also
The Supreme Court has issued notice to the Central government, National AIDS Control Organisation and others on a plea alleging a shortage of antiretroviral dru